No more equivalence trials for antibiotics in exacerbations of COPD, please

Chest. 2004 Mar;125(3):811-3. doi: 10.1378/chest.125.3.811.
No abstract available

Publication types

  • Comparative Study
  • Editorial
  • Comment

MeSH terms

  • Acute Disease
  • Anti-Bacterial Agents / therapeutic use*
  • Aza Compounds / therapeutic use
  • Bronchitis, Chronic / drug therapy*
  • Clinical Trials as Topic
  • Fluoroquinolones
  • Humans
  • Moxifloxacin
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Quinolines / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin